A prostate checkup is a preventive evaluation that combines a discussion about your risk factors and symptoms with a prostate-specific antigen (PSA) blood test and, depending on the case, a physical examination and complementary diagnostic studies. Guidelines from the American Urological Association (AUA) and the Society of Urologic Oncology (SUO) recommend that the decision to undergo PSA screening be made jointly between the patient and their physician, weighing both benefits and risks1. Its primary goal is the timely detection of clinically significant prostate cancer.
At What Age Should You Get a Prostate Checkup?
The recommended age depends on your individual risk. The 2023 AUA/SUO guideline outlines general recommendations as follows1:
- Average risk: A baseline PSA screening may be offered between ages 45 and 50.
- Increased risk (individuals of African descent, hereditary genetic mutations such as BRCA2, or a strong family history of prostate cancer): Offering baseline PSA screening between ages 40 and 45 is recommended.
- Ages 50 to 69: Regular screening every 2 to 4 years is recommended, through shared decision-making.
European guidelines (EAU) also recommend a risk-adapted strategy tailored to each man, rather than applying a one-size-fits-all approach4.
Why shared decision-making? Because PSA screening can detect cancers that require treatment, but it can also detect very slow-growing tumors that would never have caused health problems. Reviews published in the New England Journal of Medicine and in American Family Physician highlight this risk of overdiagnosis and overtreatment as the primary consideration to evaluate2,3.
What Is Prostate-Specific Antigen (PSA) and What Does an Elevated Level Mean?
PSA is a protein produced by the prostate gland that can be measured with a simple blood test2,3. An elevated level indicates that further evaluation is warranted, but it is not a diagnosis of cancer: PSA can also rise due to benign prostatic hyperplasia (enlarged prostate), inflammation, an infection (prostatitis), or other factors2,3.
When an elevated PSA is found for the first time, the AUA/SUO guideline advises repeating the test before proceeding to other diagnostic studies1. Depending on the repeat result and your risk profile, the urologist may recommend additional biomarkers or a prostate MRI, which helps determine whether a biopsy is needed and targets where to sample1,4. PSA results are always interpreted in the context of your age, prostate size, and medical history. Before the test, let your doctor know if you have had a recent urinary tract infection or any urinary tract procedure, as this information helps accurately interpret the result.
Does a Prostate Checkup Always Include a Digital Rectal Exam?
Not necessarily. The AUA/SUO guideline notes that a digital rectal exam (DRE) may be used alongside PSA to assess the risk of clinically significant cancer, but not as a standalone screening test1. The review in American Family Physician also highlights that a routine DRE alone is not recommended as a screening tool3.
In clinical practice, the urologist determines whether it provides valuable insight in your case: for example, if PSA is elevated, if you have urinary symptoms, or if evaluating the prostate's consistency and estimated size is needed. It is a brief examination that will always be explained to you before it is performed.
If I Can Urinate Normally, Is My Prostate Healthy?
Not necessarily. Early-stage prostate cancer usually causes no symptoms, so urinating normally does not rule out its presence2,3. That is why screening relies on PSA testing and risk assessment rather than waiting for symptoms. By the time prostate cancer causes noticeable symptoms, it is often in a more advanced stage—which is precisely what early detection aims to prevent2.
Conversely, having urinary symptoms (a weak stream, waking up at night to urinate, or urinary urgency) does not automatically mean you have cancer: they are frequently caused by benign prostatic hyperplasia (BPH), which also warrants professional medical evaluation.
What a Preventive Urological Checkup Includes
At the practice of Dr. Manuel Alejandro González Ramírez, specialist in Urology, Endourology, and Robotic Surgery at CURO, Centro Urológico de Occidente, each checkup is tailored to your age, risk level, and symptoms. The evaluation may include the following diagnostic studies:
| Test / Exam | Purpose | When It Is Ordered |
|---|---|---|
| Prostate-specific antigen (PSA) | Estimate the risk of prostate cancer | Based on age and risk, through shared decision-making1 |
| Physical examination (may include digital rectal exam) | Evaluate the abdomen, genitals, and prostate | As a complement to PSA testing or if symptoms are present1 |
| Ultrasound | Measure prostate size and post-void residual urine in the bladder | If urinary symptoms are present or to help interpret PSA levels |
| Uroflowmetry | Measure the flow rate and volume of the urinary stream | If there is a weak stream or difficulty urinating |
| Urinalysis | Detect infection or blood in the urine | If urinary symptoms are present or as part of a general checkup |
When to See a Urologist
Seek emergency medical attention if you experience:
- Inability to urinate (urinary retention), accompanied by lower abdominal pain.
- Fever or chills accompanied by burning or pain during urination.
- Significant visible blood in the urine or passing blood clots.
- Severe pain in the testicles or lower back accompanied by general illness.
Schedule a consultation if you received an elevated PSA result, have a family history of prostate cancer, have reached the recommended screening age and have never been checked, or have persistent urinary symptoms.
What to Expect During a Consultation with Dr. Alejandro González in Guadalajara
Dr. Alejandro González will review your family history, urinary and sexual symptoms, medical conditions, medications, and any prior PSA test results. He will explain the benefits and limitations of screening so you can decide together which studies are right for you. If any findings warrant further evaluation, he will discuss the next steps, such as repeating the PSA test or ordering a prostate MRI. Consultations take place at Centro Médico Puerta de Hierro Sur (Suite T23, 2nd floor), in southern Guadalajara, serving patients from Guadalajara, Zapopan, and Tlajomulco.
Frequently Asked Questions
How often should I have my prostate checked?
It depends on your age, individual risk, and prior test results. For men aged 50 to 69, the AUA/SUO guideline recommends regular screening every 2 to 4 years through shared decision-making, allowing the interval to be customized based on baseline PSA levels and individual risk factors1. If you have urinary symptoms or a family history of prostate cancer, your urologist may suggest a different follow-up schedule.
Does an elevated PSA mean cancer?
No. An elevated PSA indicates that further evaluation is recommended, but it can be caused by benign prostatic hyperplasia, inflammation, or infection, among other reasons2,3. That is why the AUA/SUO guideline advises repeating the test after an initial elevated result before deciding on further diagnostic procedures1. The interpretation considers your age, prostate size, and risk factors, and only a biopsy can confirm a prostate cancer diagnosis.
What happens in November (Blue November / Movember)?
November is dedicated to men's health awareness, widely known as Blue November or Movember, raising awareness about prostate cancer and preventive urological checkups. It serves as an excellent reminder to schedule an exam, although screening should not be limited to a specific month: what matters most is getting checked according to your age and personal risk, and maintaining the follow-up recommended by your urologist.
If you are at the recommended age for screening or have a PSA result of concern, learn more about a prostate checkup in Guadalajara. The overall cost depends on the specific studies required and your coverage, which will be confirmed during your consultation; review our health insurance information. You can also read more about prostate cancer in Guadalajara and enlarged prostate in Guadalajara.
Referencias
- Wei JT, Barocas DA, Carlsson S, et al. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. American Urological Association; julio de 2023.
- Pinsky PF, Parnes H. Screening for Prostate Cancer. New England Journal of Medicine. 13 de abril de 2023.
- Xu, McPharlin, Mulhem. Prostate Cancer Screening: Common Questions and Answers. American Family Physician. Noviembre de 2024.
- Cornford P, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2026 Update. Part I: Screening, Diagnosis, and Local Treatment With Curative Intent. European Urology. 1 de septiembre de 2026.
